Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism

Circulation

Volumn 102, Issue 2, 2000, Pages 211-217

  Giannitsis, Evangelos ^b   Müller Bardorff, Margit ^b   Kurowski, Volkhard ^b   Weidtmann, Britta ^b   Wiegand, Uwe ^b   Kampmann, Markus ^b   Katus, Hugo A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NONE

Author keywords

Coronary disease; Embolism; Pulmonary heart disease

Indexed keywords

TROPONIN T;

AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RESUSCITATION; TREATMENT OUTCOME;

EID: 0343517175     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.2.211     Document Type: Article

References (30)

1. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase plus heparin in acute pulmonary embolism: randomized trial assessing right ventricular function and pulmonary perfusion. Lancet. 1993;341:507-511.
2. Kasper W, Konstantinides S, Geibel A, et al. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart. 1997;77:346-349.
3. Konstantinides S, Geibel A, Olschewski M, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Circulation. 1997;96:882-888.
4. Wolfe MW, Lee RT, Feldstein ML, et al. Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism. Am Heart J. 1994;127:1371-1375.
5. Goldhaber SZ, Visani L, De Rosa M, for ICOPER. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386-1389.
6. Vlahakes GJ, Turley K, Hoffman JIE. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation. 1981;63:87-95.
7. Henry PD, Bloor CM, Sobel BE. Increased serum creatine phosphokinase activity in experimental pulmonary embolism. Am J Cardiol. 1970;26:151-155.
8. Adams JE III, Siegel BA, Goldstein JA, et al. Elevations of CK-MB following pulmonary embolism. Chest. 1992;101:1203-1206.
9. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Mean J. 1995;130:1276-1282.
10. Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 1991;83:902-912.
11. Rottbauer W, Greten T, Müller-Bardorff M, et al. Troponin T: a diagnostic marker for myocardial infarction and minor cardiac cell damage. Eur Heart J. 1996;17(suppl F):3-8.
12. Ohman EM, Armstrong PW, Christenson RH, et al, for the GUSTO-IIa-Investigators. Cardiac troponin T levels for risk stratification in acute myocardial infarction. N Engl J Med. 1996;335:1333-1341.
13. Lindahl B, Venge P, Wallentin L, for the FRISC Study Group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation. 1996;93:1651-1657.
14. Ravkilde J, Nissen H, Horder M, et al. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. J Am Coll Cardiol. 1995;25:574-581.
15. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146-150.
16. Daniels LB, Parker JA, Patel SR, et al. Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol. 1997;80:184-188.
17. Goldhaber SZ. Treatment of acute pulmonary embolism. In: Braunwald E, Goldhaber SZ, eds. Atlas of Heart Disease. Vol 3: Cardiopulmonary Diseases and Cardiac Tumors. Philadelphia Pa: Current Medicine; 1995.
18. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997;30:1165-1171.
19. Müller-Bardorff M, Freitag H, Scheffold T, et al. Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation. 1995;92:2869-2875.
20. Horn H, Dack S, Friedberg CK. Cardiac sequelae of embolism of the pulmonary artery. Arch Intern Med. 1939;64:296-321.
21. Belenkie I, Dani R, Smith ER, et al. Ventricular interaction during experimental acute pulmonary embolism. Circulation. 1988;78: 761-768.
22. Prewitt RM. Hemodynamic management in pulmonary embolism and acute hypoxemic respiratory failure. Crit Care Med. 1990;18:S61-S69.
23. McIntyre KM, Sasahara AA. The ratio of pulmonary artery pressure to pulmonary vascular obstruction. Chest. 1977;71:692-699.
24. Bahrmann VE, Kleinschmidt HJ, Rann W. Der Rechtsherzinfarkt und seine Beziehung zum chronischen cor pulmonale. Zentralbl Allg Pathol. 1976;120:88-90.
25. Coma-Canella I, Gamello C, Martinez-Onsurbe P, et al. Acute right ventricular infarction secondary to massive pulmonary embolism. Eur Heart J. 1988;9:534-540.
26. Jerjes-Sanchez C, Gutierrez-Fajardo P, Ramirez-Rivera A, et al. Acute infarct of the right ventricle secondary to a massive pulmonary thromboembolism. Arch Inst Cardiol Mex. 1995;65:65-73.
27. Pacouret G, Schellenberg F, Hamel E, et al. Troponine I dans l'embolie pulmonaire aigue massive: resultats d'une serie prospective. Presse Med. 1998;27:1627.
28. Kasper W, Meinertz T, Henkel B, et al. Echocardiographic findings in patients with proved pulmonary embolism. Am Heart J. 1986;112: 1284-1290.
29. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992;326:1240-1245.
30. Alpert JS, Smith R, Carlson J, et al. Mortality in patients treated for pulmonary embolism. JAMA. 1976;236:1477-1480.